Information for "Intralesional rituximab inside the treating indolent main cutaneous Bcell lymphoma"
From EECH Central
Basic information
| Display title | Intralesional rituximab inside the treating indolent main cutaneous Bcell lymphoma |
| Default sort key | Intralesional rituximab inside the treating indolent main cutaneous Bcell lymphoma |
| Page length (in bytes) | 4,156 |
| Page ID | 545824 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Smashcell4 (Talk | contribs) |
| Date of page creation | 10:04, 3 September 2023 |
| Latest editor | Nutlock06 (Talk | contribs) |
| Date of latest edit | 15:16, 27 April 2024 |
| Total number of edits | 3 |
| Total number of distinct authors | 3 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
